US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist

19.640
-0.210-1.06%

Close Dec 2 16:00 ET

19.640
0.0000.00%

Post 20:01 ET

1.81BMarket Cap-8886P/E (TTM)

NewAmsterdam Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Total revenue

889.83%29.11M

32.73%2.28M

-83.76%1.4M

-86.28%14.09M

803K

2.94M

1.72M

8.63M

102.69M

Operating revenue

889.83%29.11M

32.73%2.28M

-83.76%1.4M

-86.28%14.09M

--803K

--2.94M

--1.72M

--8.63M

--102.69M

--0

Cost of revenue

Gross profit

Operating expense

3.43%52.98M

31.83%53.68M

18.48%55.99M

87.77%189.2M

50M

51.22M

40.72M

47.26M

190.78%100.76M

433.78%34.65M

Selling and administrative expenses

120.01%17.28M

139.97%15.3M

98.33%13.56M

112.42%29.77M

--8.71M

--7.85M

--6.38M

--6.84M

146.87%14.02M

274.65%5.68M

-Selling and marketing expense

210.51%3.55M

650.96%3.52M

559.39%4.08M

137.33%4.06M

--1.83M

--1.14M

--469K

--618K

74.92%1.71M

7,121.27%977K

-General and administrative expense

104.60%13.73M

99.39%11.78M

52.52%9.49M

108.96%25.72M

--6.88M

--6.71M

--5.91M

--6.22M

161.83%12.31M

212.96%4.7M

Research and development costs

-17.68%35.7M

11.76%38.38M

4.97%42.43M

83.79%159.42M

--41.29M

--43.37M

--34.34M

--40.42M

199.39%86.74M

482.37%28.97M

Operating profit

50.57%-23.87M

-31.79%-51.4M

-41.32%-54.59M

-9,149.35%-175.11M

-49.2M

-48.28M

-39M

-38.63M

105.58%1.94M

-433.78%-34.65M

Net non-operating interest income expense

85.43%3.31M

226.81%3.69M

876.60%2.19M

159.20%3.42M

789K

1.78M

1.13M

-282K

-684.12%-5.78M

-21.05%-737K

Non-operating interest income

45.24%4.44M

5.57%4.87M

226.94%3.08M

--11.28M

--2.67M

--3.06M

--4.61M

--943K

--0

Non-operating interest expense

----

--0

----

-30.17%287K

-2.86%411K

Total other finance cost

-10.98%1.14M

-66.21%1.18M

-27.10%893K

43.15%7.86M

--1.88M

--1.28M

--3.48M

--1.23M

1,584.66%5.49M

75.53%326K

Other net income (expense)

717.03%3.91M

2,161.14%8.7M

-1,231.02%-41.37M

72.19%-5.23M

-1.06M

-634K

-422K

-3.11M

-193.73%-18.79M

-21,770.90%-6.4M

Gain on sale of security

717.03%3.91M

2,161.14%8.7M

-1,231.02%-41.37M

51.56%-5.23M

---1.06M

---634K

---422K

---3.11M

-732.36%-10.79M

5,679.36%1.71M

Special income (charges)

----

--0

----

--0

---883K

-Less:Other special charges

----

--883K

Other non- operating income (expenses)

----

-10.83%-8M

---7.22M

Income before tax

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

-681.61%-176.91M

-49.47M

-47.13M

-38.29M

-42.02M

45.83%-22.63M

-490.94%-41.79M

Income tax

-1K

27K

Net income

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

-681.73%-176.94M

-49.5M

-47.13M

-38.29M

-42.02M

45.83%-22.63M

-490.94%-41.79M

Net income continuous Operations

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

-681.73%-176.94M

---49.5M

---47.13M

---38.29M

---42.02M

45.83%-22.63M

-490.94%-41.79M

Minority interest income

Net income attributable to the parent company

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

-681.73%-176.94M

-49.5M

-47.13M

-38.29M

-42.02M

45.83%-22.63M

-490.94%-41.79M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

-681.73%-176.94M

-49.5M

-47.13M

-38.29M

-42.02M

45.83%-22.63M

-490.94%-41.79M

Basic earnings per share

68.42%-0.18

12.77%-0.41

-107.84%-1.06

-80.67%-2.15

-0.6

-0.57

-0.47

-0.51

-132.27%-1.19

-490.94%-0.5123

Diluted earnings per share

68.42%-0.18

12.77%-0.41

-107.84%-1.06

-80.67%-2.15

-0.6

-0.57

-0.47

-0.51

-132.27%-1.19

-490.94%-0.5123

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Total revenue	889.83%29.11M	32.73%2.28M	-83.76%1.4M	-86.28%14.09M	803K	2.94M	1.72M	8.63M	102.69M	0
Operating revenue	889.83%29.11M	32.73%2.28M	-83.76%1.4M	-86.28%14.09M	--803K	--2.94M	--1.72M	--8.63M	--102.69M	--0
Cost of revenue
Gross profit
Operating expense	3.43%52.98M	31.83%53.68M	18.48%55.99M	87.77%189.2M	50M	51.22M	40.72M	47.26M	190.78%100.76M	433.78%34.65M
Selling and administrative expenses	120.01%17.28M	139.97%15.3M	98.33%13.56M	112.42%29.77M	--8.71M	--7.85M	--6.38M	--6.84M	146.87%14.02M	274.65%5.68M
-Selling and marketing expense	210.51%3.55M	650.96%3.52M	559.39%4.08M	137.33%4.06M	--1.83M	--1.14M	--469K	--618K	74.92%1.71M	7,121.27%977K
-General and administrative expense	104.60%13.73M	99.39%11.78M	52.52%9.49M	108.96%25.72M	--6.88M	--6.71M	--5.91M	--6.22M	161.83%12.31M	212.96%4.7M
Research and development costs	-17.68%35.7M	11.76%38.38M	4.97%42.43M	83.79%159.42M	--41.29M	--43.37M	--34.34M	--40.42M	199.39%86.74M	482.37%28.97M
Operating profit	50.57%-23.87M	-31.79%-51.4M	-41.32%-54.59M	-9,149.35%-175.11M	-49.2M	-48.28M	-39M	-38.63M	105.58%1.94M	-433.78%-34.65M
Net non-operating interest income expense	85.43%3.31M	226.81%3.69M	876.60%2.19M	159.20%3.42M	789K	1.78M	1.13M	-282K	-684.12%-5.78M	-21.05%-737K
Non-operating interest income	45.24%4.44M	5.57%4.87M	226.94%3.08M	--11.28M	--2.67M	--3.06M	--4.61M	--943K	--0	--0
Non-operating interest expense	----	----	----	--0	----	----	----	----	-30.17%287K	-2.86%411K
Total other finance cost	-10.98%1.14M	-66.21%1.18M	-27.10%893K	43.15%7.86M	--1.88M	--1.28M	--3.48M	--1.23M	1,584.66%5.49M	75.53%326K
Other net income (expense)	717.03%3.91M	2,161.14%8.7M	-1,231.02%-41.37M	72.19%-5.23M	-1.06M	-634K	-422K	-3.11M	-193.73%-18.79M	-21,770.90%-6.4M
Gain on sale of security	717.03%3.91M	2,161.14%8.7M	-1,231.02%-41.37M	51.56%-5.23M	---1.06M	---634K	---422K	---3.11M	-732.36%-10.79M	5,679.36%1.71M
Special income (charges)	----	----	----	--0	----	----	----	----	--0	---883K
-Less:Other special charges	----	----	----	----	----	----	----	----	----	--883K
Other non- operating income (expenses)	----	----	----	----	----	----	----	----	-10.83%-8M	---7.22M
Income before tax	64.68%-16.65M	-1.87%-39.01M	-123.16%-93.77M	-681.61%-176.91M	-49.47M	-47.13M	-38.29M	-42.02M	45.83%-22.63M	-490.94%-41.79M
Income tax	-1K	0	0	27K	27K	0	0	0	0	0
Net income	64.68%-16.65M	-1.87%-39.01M	-123.16%-93.77M	-681.73%-176.94M	-49.5M	-47.13M	-38.29M	-42.02M	45.83%-22.63M	-490.94%-41.79M
Net income continuous Operations	64.68%-16.65M	-1.87%-39.01M	-123.16%-93.77M	-681.73%-176.94M	---49.5M	---47.13M	---38.29M	---42.02M	45.83%-22.63M	-490.94%-41.79M
Minority interest income
Net income attributable to the parent company	64.68%-16.65M	-1.87%-39.01M	-123.16%-93.77M	-681.73%-176.94M	-49.5M	-47.13M	-38.29M	-42.02M	45.83%-22.63M	-490.94%-41.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	64.68%-16.65M	-1.87%-39.01M	-123.16%-93.77M	-681.73%-176.94M	-49.5M	-47.13M	-38.29M	-42.02M	45.83%-22.63M	-490.94%-41.79M
Basic earnings per share	68.42%-0.18	12.77%-0.41	-107.84%-1.06	-80.67%-2.15	-0.6	-0.57	-0.47	-0.51	-132.27%-1.19	-490.94%-0.5123
Diluted earnings per share	68.42%-0.18	12.77%-0.41	-107.84%-1.06	-80.67%-2.15	-0.6	-0.57	-0.47	-0.51	-132.27%-1.19	-490.94%-0.5123
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data